CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Companies›
Boston Scientific›
Products & Services›
Cardiac Rhythm Management
Cardiac Rhythm Management logo

Boston Scientific› offers Cardiac Rhythm Management

ProductOperating Status: Currently Offered

Boston Scientific's cardiac rhythm management portfolio spans defibrillators, CRT devices, pacing catheters, and implantable device bioenvelopes.

Loading
Overview

Boston Scientific's cardiac rhythm management portfolio delivers implantable devices and technologies for defibrillation, cardiac resynchronization, and conduction system pacing. Featured products include the EMBLEM MRI S-ICD system, a subcutaneous implantable defibrillator that provides defibrillation therapy without transvenous leads, and the RESONATE CRT-D for patients with heart failure who may benefit from coordinated ventricular pacing.

Supporting technologies include EnduraLife battery technology for extended device longevity and the EluPro antibiotic-eluting bioenvelope, a biomatrix designed to reduce cardiac implantable electronic device infections. Site Selective Pacing Catheters support efficient lead placement during conduction system pacing procedures, including left bundle branch area pacing.

Cardiac Rhythm Management - Classification

Industry
  • Medical Device Manufacturing

More from Boston Scientific

  • ROTAPRO Rotational Atherectomy System logo

    ROTAPRO Rotational Atherectomy System

  • WaveWriter Alpha Spinal Cord Stimulator System logo

    WaveWriter Alpha Spinal Cord Stimulator System

  • Latitude NXT logo

    Latitude NXT

  • HeartLogic logo

    HeartLogic

  • Vercise Neural Navigator 5 logo

    Vercise Neural Navigator 5

Cardiac Rhythm Management - Direct Competitors

  • BIOTRONIK

    BIOTRONIK logo

    Cardiac Rhythm Management

    biotronik.com

  • Medtronic

    Medtronic logo

    Cardiac Rhythm Management

    medtronic.com

  • Abbott

    Abbott logo

    Cardiac Rhythm Management

    abbott.com

AttributeCardiac Rhythm ManagementCardiac Rhythm ManagementCardiac Rhythm ManagementCardiac Rhythm Management
ProviderBoston Scientificbostonscientific.com$6.3B disclosed funding · PublicBIOTRONIKbiotronik.comMedtronicmedtronic.com$5.9B disclosed funding · PublicAbbottabbott.com
Founded1979196319491910
Sells ToConsumers, EnterpriseHospitalsConsumers, Enterprise—
Pricing ModelRecurring, Software, Transactional—Recurring, Transactional—
OwnershipPublicPrivatePublic—
Cardiac Rhythm Management

Provider Boston Scientificbostonscientific.com$6.3B disclosed funding · Public

Founded 1979

Sells To Consumers, Enterprise

Pricing Model Recurring, Software, Transactional

Ownership Public

Cardiac Rhythm Management

Provider BIOTRONIKbiotronik.com

Founded 1963

Sells To Hospitals

Pricing Model —

Ownership Private

Cardiac Rhythm Management

Provider Medtronicmedtronic.com$5.9B disclosed funding · Public

Founded 1949

Sells To Consumers, Enterprise

Pricing Model Recurring, Transactional

Ownership Public

Cardiac Rhythm Management

Provider Abbottabbott.com

Founded 1910

Sells To —

Pricing Model —

Ownership —